Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

for
Breast Cancer, HER2-positive Breast Cancer,
Location: Hershey PA, Rochester NY, Chicago IL, Madison WI
Sponsor: Ruth O'Regan

Sex: All

Age: 18+

Code: NCT04886531

Phase 2, Recruiting

Pilot Trial of Spiritual Care Interventions for Patients With Cancer

for
Advanced Cancer
Location: Brooklyn NY, Galveston TX
Sponsor: Weill Medical College of Cornell University

Sex: All

Age: 18+

Code: NCT06811376

Recruiting

Breast Mesh Used in Two-staged Breast Reconstruction

for
Breast Cancer, Radiation, Breast Reconstruction, Synthetic Mesh
Location: Houston TX
Sponsor: Tianjin Medical University Cancer Institute and Hospital

Sex: Female

Age: 18 - 70

Code: NCT04967976

Recruiting

With Love, Grandma ("Con Cariño, Abuelita") Pilot Study

for
Cancer, Breast, Cancer, Uterus, Cancer, Ovary, Obesity,
Location: Miami FL
Sponsor: University of Miami Sylvester Comprehensive Cancer Center

Sex: Female

Age: 21+

Code: NCT05721976

Recruiting

A Study of EBC-129 in Advanced Solid Tumours

for
Advanced Solid Tumours
Location: Houston TX, Aurora CO
Sponsor: EDDC (Experimental Drug Development Centre), A*STAR Research Entities

Sex: All

Age: 18+

Code: NCT05701527

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

for
Breast Cancer, Quality of Life
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: Female

Age: 65+

Code: NCT05472792

Phase 2, Recruiting

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

for
Breast Cancer, Stage III Breast Cancer, Breast Cancer Female,
Location: Boston MA, State College PA, Pittsburgh PA,
Sponsor: Dana-Farber Cancer Institute

Sex: Female

Age: 65+

Code: NCT05535192

Recruiting

Converting HR+ Breast Cancer Into an Individualized Vaccine

for
Breast Cancer
Location: New York NY, Houston TX, Dallas TX
Sponsor: Weill Medical College of Cornell University

Sex: Female

Age: 18 - 70+

Code: NCT03804944

Phase 2, Recruiting

Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer

for
Breast Cancer
Location: Chicago IL
Sponsor: Northwestern University

Sex: Female

Age: 0+

Code: NCT00898131

Recruiting

Virtual Rehabilitation for Cancer Survivors

for
Breast Cancer, Stage 0, Colorectal Cancer Stage I,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT05898789

Recruiting

Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)

for
Breast Neoplasms, Breast Cancer
Location: Boston MA, New Brunswick NJ, Montreal, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06686394

Phase 1, Phase 2, Recruiting

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

for
Solid Tumors, Neoplasms
Location: Boston MA, Mineola NY, New York NY, Toronto, Montreal,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06431594

Phase 1, Recruiting

Living Well With Advanced Breast Cancer

for
Advanced Breast Carcinoma,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07227038

Recruiting

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

for
Advanced Cancer, Clear Cell Renal Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT05663710

Phase 1, Phase 2, Recruiting

Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer

for
Breast Carcinoma, Colorectal Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06130826

Phase 1, Recruiting

Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases

for
Metastatic Malignant Neoplasm in the Bone,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT06549478

Phase 1, Recruiting

Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors

for
Obesity and Overweight, Breast Cancer Survivorship
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore

Sex: Female

Age: 0+

Code: NCT07032545

Recruiting

Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics

for
Pediatric Cancer
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18+

Code: NCT07288476

Recruiting

A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes

for
Breast Cancer, Diabetes Type II
Location: Mineola NY, New York NY, Washington D.C. DC,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07748208

Phase 2, Recruiting

T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd

for
Advanced Breast Cancer, Metastatic Breast Cancer, HER2 Positive,
Location: Columbia MD, Fairfax VA, Nashville TN, New Braunfels TX,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT07683754

Phase 3, Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial